Emilia Staniewska April 27, 2024 Cancers (Basel). 2024 Apr 18;16(8):1542. doi: 10.3390/cancers16081542. ABSTRACT INTRODUCTION: There is growing interest in the prognostic value of routinely performed pre-treatment blood test indices, such as the RDW or SII, with the latter combining the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR). These indices were shown to be prognostic for…
Read more →